|
|
||||||||
From the Department of Neurological and Visual Sciences, Section of Clinical Neurology, University of Verona, Italy.
Address correspondence and reprint requests to Dr. G.M. Fabrizi, Section of Clinical Neurology, Department of Neurological and Visual Sciences, University of Verona, Policlinico G.B. Rossi, P.le L.A. Scuro 10, 37134 Verona, Italy; e-mail: gianmaria.fabrizi{at}univr.it
The axonal type 2 CharcotMarieTooth disease (CMT2) is phenotypically poorly characterized. Here the authors report a family with a Pro22Ser mutation in the neurofilament-light gene (NF-L; CMT2E) manifesting electrophysiologically as the demyelinating type 1 CMT (CMT1) and pathologically as an axonopathy with giant axons and accumulation of disorganized NF. NF-L should be investigated in CMT2 as well as in CMT1 not associated with the usual genes PMP22, Cx32, and P0.
Received August 14, 2003. Accepted in final form December 15, 2003.
Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the April 27 issue to find the title link for this article.
This article has been cited by other articles:
![]() |
J. Zhai, H. Lin, J.-P. Julien, and W. W. Schlaepfer Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot Marie Tooth disease-linked mutations in NFL and HSPB1 Hum. Mol. Genet., December 15, 2007; 16(24): 3103 - 3116. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Houlden, M. Groves, Z. Miedzybrodzka, H. Roper, T. Willis, J. Winer, G. Cole, and M. M Reilly New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1267 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Fabrizi, M. Ferrarini, T. Cavallaro, I. Cabrini, R. Cerini, L. Bertolasi, and N. Rizzuto Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease Neurology, July 17, 2007; 69(3): 291 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Miltenberger-Miltenyi, A. R. Janecke, J. V. Wanschitz, V. Timmerman, C. Windpassinger, M. Auer-Grumbach, and W. N. Loscher Clinical and Electrophysiological Features in Charcot-Marie-Tooth Disease With Mutations in the NEFL Gene Arch Neurol, July 1, 2007; 64(7): 966 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Fabrizi, T. Cavallaro, C. Angiari, I. Cabrini, F. Taioli, G. Malerba, L. Bertolasi, and N. Rizzuto Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton Brain, February 1, 2007; 130(2): 394 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Azzedine, N. Ravise, C. Verny, A. Gabreels-Festen, M. Lammens, D. Grid, J. M. Vallat, G. Durosier, J. Senderek, S. Nouioua, et al. Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations. Neurology, August 22, 2006; 67(4): 602 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sasaki, T. Gotow, M. Shiozaki, F. Sakaue, T. Saito, J.-P. Julien, Y. Uchiyama, and S.-I. Hisanaga Aggregate formation and phosphorylation of neurofilament-L Pro22 Charcot-Marie-Tooth disease mutants Hum. Mol. Genet., March 15, 2006; 15(6): 943 - 952. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |